SlideShare une entreprise Scribd logo

Hungarian Investment and Trade Development Authority

•Télécharger en tant que PPT, PDF•
•
G
Global Sourcing Council

Hungary has a strong pharmaceutical industry with large international companies conducting R&D and manufacturing. It has a skilled workforce, lower costs than Western Europe, and university collaboration which supports the sector. Recent investments have expanded R&D, manufacturing, and clinical trials in Hungary. Clusters around universities in Budapest, Szeged, Debrecen and Pécs enhance academia-business cooperation in life sciences. Hungary also has regulatory systems harmonized with the EU and a competitive innovation ecosystem.

BusinessFormation
1  sur  14
 
Long t radition , n ew FDI into R&D ,[object Object],[object Object],[object Object]
WHY HUNGARY ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Added value of the pharma sector
[object Object],[object Object],[object Object],[object Object],Life sciences A High Performing Sector
Latest investments in the life sciences sector ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Latest investments in the life sciences sector
Nanotechnology in Hungary ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Medical device manufacturing ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Clinical trials ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Strong innovation capacity ,[object Object],Source: Global Comp e titiveness Report, World Economic Forum, 2006/ 2007 Ranking Country Switzerland 1 USA 2 Germany 5 France 19 Norway 21 Hungary 24 Czech Republic 30 Slovenia 33 Spain 49 China 56 Poland 64 Greece 76
Four life science clusters ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Genomnanotech Knowledge Centre Neurobiological Knowledge Centre Cell Communication Knowledge Centre Infobionics Knowledge Centre Medipolis Knowledge Centre Debrecen Szeged Budapest Pécs
Competitive wages compared to Western Europe Source: Mercer, 2007
Regulatory system ,[object Object],[object Object],[object Object],[object Object],[object Object]

Recommandé

HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen
HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen
HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen Business Turku
 
HealthBIO 2021_Opening words_Maarit Merla
HealthBIO 2021_Opening words_Maarit MerlaHealthBIO 2021_Opening words_Maarit Merla
HealthBIO 2021_Opening words_Maarit MerlaBusiness Turku
 
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...Business Turku
 
Innovation drives expansion, Titus Gylvin
Innovation drives expansion, Titus Gylvin Innovation drives expansion, Titus Gylvin
Innovation drives expansion, Titus Gylvin Business Turku
 
Chapter 2: Trailblazing science
Chapter 2: Trailblazing scienceChapter 2: Trailblazing science
Chapter 2: Trailblazing scienceAssociation of the British Pharmaceutical Industry (ABPI)
 
Life science instrumentations market
Life science instrumentations marketLife science instrumentations market
Life science instrumentations marketameliasimon0
 
EuroBioForum 2013 - Day 1 | Wolfgang Eberle
EuroBioForum 2013 - Day 1 | Wolfgang Eberle EuroBioForum 2013 - Day 1 | Wolfgang Eberle
EuroBioForum 2013 - Day 1 | Wolfgang EberleEuroBioForum
 
Antimicrobial Resistance (AMR) in the UK & Germany: Synergies, Opportunities ...
Antimicrobial Resistance (AMR) in the UK & Germany: Synergies, Opportunities ...Antimicrobial Resistance (AMR) in the UK & Germany: Synergies, Opportunities ...
Antimicrobial Resistance (AMR) in the UK & Germany: Synergies, Opportunities ...KTN
 

Recommandé

HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen
HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen
HealthBIO 2021_Finnish biotech year 2021_Tero Piispanen Business Turku
 
HealthBIO 2021_Opening words_Maarit Merla
HealthBIO 2021_Opening words_Maarit MerlaHealthBIO 2021_Opening words_Maarit Merla
HealthBIO 2021_Opening words_Maarit MerlaBusiness Turku
 
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...
HealthBIO 2021_PerkinElmer, leading with innovation - from COVID success into...Business Turku
 
Innovation drives expansion, Titus Gylvin
Innovation drives expansion, Titus Gylvin Innovation drives expansion, Titus Gylvin
Innovation drives expansion, Titus Gylvin Business Turku
 
Chapter 2: Trailblazing science
Chapter 2: Trailblazing scienceChapter 2: Trailblazing science
Chapter 2: Trailblazing scienceAssociation of the British Pharmaceutical Industry (ABPI)
 
Life science instrumentations market
Life science instrumentations marketLife science instrumentations market
Life science instrumentations marketameliasimon0
 
EuroBioForum 2013 - Day 1 | Wolfgang Eberle
EuroBioForum 2013 - Day 1 | Wolfgang Eberle EuroBioForum 2013 - Day 1 | Wolfgang Eberle
EuroBioForum 2013 - Day 1 | Wolfgang EberleEuroBioForum
 
Antimicrobial Resistance (AMR) in the UK & Germany: Synergies, Opportunities ...
Antimicrobial Resistance (AMR) in the UK & Germany: Synergies, Opportunities ...Antimicrobial Resistance (AMR) in the UK & Germany: Synergies, Opportunities ...
Antimicrobial Resistance (AMR) in the UK & Germany: Synergies, Opportunities ...KTN
 
Market elements of the biopharmaceutical market and single-use technologies
Market elements of the biopharmaceutical market and single-use technologiesMarket elements of the biopharmaceutical market and single-use technologies
Market elements of the biopharmaceutical market and single-use technologiesBenoit Massé
 
Case study examples from industry
Case study examples from industryCase study examples from industry
Case study examples from industryAssociation of the British Pharmaceutical Industry (ABPI)
 
Chapter 5: The future
Chapter 5: The futureChapter 5: The future
Chapter 5: The futureAssociation of the British Pharmaceutical Industry (ABPI)
 
Technology scouting at Bayer Healthcare
Technology scouting at Bayer HealthcareTechnology scouting at Bayer Healthcare
Technology scouting at Bayer Healthcareinosfera
 
To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...
To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...
To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...Upgraded - Health Startup Association of Finland
 
How Patent and Regulatory Exclusivity can Protect Your Medical Device Business
How Patent and Regulatory Exclusivity can Protect Your Medical Device BusinessHow Patent and Regulatory Exclusivity can Protect Your Medical Device Business
How Patent and Regulatory Exclusivity can Protect Your Medical Device BusinessMichael Weickert, Ph.D
 
Chapter 4: Letting innovation flourish
Chapter 4: Letting innovation flourishChapter 4: Letting innovation flourish
Chapter 4: Letting innovation flourishAssociation of the British Pharmaceutical Industry (ABPI)
 
Chapter 3: Putting patients first
Chapter 3: Putting patients firstChapter 3: Putting patients first
Chapter 3: Putting patients firstAssociation of the British Pharmaceutical Industry (ABPI)
 
Merck & co., inc. barclays final 3-10-2015
Merck & co., inc. barclays final 3-10-2015Merck & co., inc. barclays final 3-10-2015
Merck & co., inc. barclays final 3-10-2015Marcel Brussee
 
Merck group 7 strategic_mgmt
Merck group 7 strategic_mgmtMerck group 7 strategic_mgmt
Merck group 7 strategic_mgmtkirtishankar075
 
Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...
Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...
Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...Will Roettger
 
Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)
Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)
Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)Vitor Pereira
 
Venipuncture needle and syringes market
Venipuncture needle and syringes marketVenipuncture needle and syringes market
Venipuncture needle and syringes marketAkshay Shinde
 
Innovative Infectious Disease Testing Technologies and Emerging Markets
Innovative Infectious Disease Testing Technologies and Emerging MarketsInnovative Infectious Disease Testing Technologies and Emerging Markets
Innovative Infectious Disease Testing Technologies and Emerging MarketsReportsnReports
 
COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market
COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market
COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market NarayanSharma67
 
Introduction to the pharmaceutical market and practice
Introduction to the pharmaceutical market and practiceIntroduction to the pharmaceutical market and practice
Introduction to the pharmaceutical market and practiceWayne Wei
 
The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...
The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...
The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...PhRMA
 
Antibody drug conjugate market opportunity analysis
Antibody drug conjugate market opportunity analysisAntibody drug conjugate market opportunity analysis
Antibody drug conjugate market opportunity analysisRajesh Sarma
 
Pharma figures 2017 ; Efpia
Pharma figures 2017 ; EfpiaPharma figures 2017 ; Efpia
Pharma figures 2017 ; EfpiaGuru Balaji .S
 
Blog april2016 companycreation
Blog april2016 companycreationBlog april2016 companycreation
Blog april2016 companycreationNutopya Life Science
 
ABA Life Sciences
ABA Life Sciences ABA Life Sciences
ABA Life Sciences ABA - Invest in Austria
 
Imre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystem
Imre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystemImre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystem
Imre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystemCUBCCE Conference
 

Contenu connexe

Tendances

Market elements of the biopharmaceutical market and single-use technologies
Market elements of the biopharmaceutical market and single-use technologiesMarket elements of the biopharmaceutical market and single-use technologies
Market elements of the biopharmaceutical market and single-use technologiesBenoit Massé
 
Technology scouting at Bayer Healthcare
Technology scouting at Bayer HealthcareTechnology scouting at Bayer Healthcare
Technology scouting at Bayer Healthcareinosfera
 
How Patent and Regulatory Exclusivity can Protect Your Medical Device Business
How Patent and Regulatory Exclusivity can Protect Your Medical Device BusinessHow Patent and Regulatory Exclusivity can Protect Your Medical Device Business
How Patent and Regulatory Exclusivity can Protect Your Medical Device BusinessMichael Weickert, Ph.D
 
Merck & co., inc. barclays final 3-10-2015
Merck & co., inc. barclays final 3-10-2015Merck & co., inc. barclays final 3-10-2015
Merck & co., inc. barclays final 3-10-2015Marcel Brussee
 
Merck group 7 strategic_mgmt
Merck group 7 strategic_mgmtMerck group 7 strategic_mgmt
Merck group 7 strategic_mgmtkirtishankar075
 
Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...
Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...
Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...Will Roettger
 
Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)
Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)
Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)Vitor Pereira
 
Venipuncture needle and syringes market
Venipuncture needle and syringes marketVenipuncture needle and syringes market
Venipuncture needle and syringes marketAkshay Shinde
 
Innovative Infectious Disease Testing Technologies and Emerging Markets
Innovative Infectious Disease Testing Technologies and Emerging MarketsInnovative Infectious Disease Testing Technologies and Emerging Markets
Innovative Infectious Disease Testing Technologies and Emerging MarketsReportsnReports
 
COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market
COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market
COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market NarayanSharma67
 
Introduction to the pharmaceutical market and practice
Introduction to the pharmaceutical market and practiceIntroduction to the pharmaceutical market and practice
Introduction to the pharmaceutical market and practiceWayne Wei
 
The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...
The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...
The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...PhRMA
 
Antibody drug conjugate market opportunity analysis
Antibody drug conjugate market opportunity analysisAntibody drug conjugate market opportunity analysis
Antibody drug conjugate market opportunity analysisRajesh Sarma
 
Pharma figures 2017 ; Efpia
Pharma figures 2017 ; EfpiaPharma figures 2017 ; Efpia
Pharma figures 2017 ; EfpiaGuru Balaji .S
 

Tendances (20)

Market elements of the biopharmaceutical market and single-use technologies
Market elements of the biopharmaceutical market and single-use technologiesMarket elements of the biopharmaceutical market and single-use technologies
Market elements of the biopharmaceutical market and single-use technologies
 
Case study examples from industry
Case study examples from industryCase study examples from industry
Case study examples from industry
 
Chapter 5: The future
Chapter 5: The futureChapter 5: The future
Chapter 5: The future
 
Technology scouting at Bayer Healthcare
Technology scouting at Bayer HealthcareTechnology scouting at Bayer Healthcare
Technology scouting at Bayer Healthcare
 
To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...
To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...
To Partner, or Not to Partner, that is Not the Question. Gregor Fachinger, BA...
 
How Patent and Regulatory Exclusivity can Protect Your Medical Device Business
How Patent and Regulatory Exclusivity can Protect Your Medical Device BusinessHow Patent and Regulatory Exclusivity can Protect Your Medical Device Business
How Patent and Regulatory Exclusivity can Protect Your Medical Device Business
 
Chapter 4: Letting innovation flourish
Chapter 4: Letting innovation flourishChapter 4: Letting innovation flourish
Chapter 4: Letting innovation flourish
 
Chapter 3: Putting patients first
Chapter 3: Putting patients firstChapter 3: Putting patients first
Chapter 3: Putting patients first
 
Merck & co., inc. barclays final 3-10-2015
Merck & co., inc. barclays final 3-10-2015Merck & co., inc. barclays final 3-10-2015
Merck & co., inc. barclays final 3-10-2015
 
Merck group 7 strategic_mgmt
Merck group 7 strategic_mgmtMerck group 7 strategic_mgmt
Merck group 7 strategic_mgmt
 
Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...
Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...
Type-2 Diabetes Competitor Threat Assessment - Bydureon DURATION-4 Briefing ...
 
Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)
Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)
Earma Annual Conference 23 june 2011 - Magali Poinot (part 1)
 
Venipuncture needle and syringes market
Venipuncture needle and syringes marketVenipuncture needle and syringes market
Venipuncture needle and syringes market
 
Innovative Infectious Disease Testing Technologies and Emerging Markets
Innovative Infectious Disease Testing Technologies and Emerging MarketsInnovative Infectious Disease Testing Technologies and Emerging Markets
Innovative Infectious Disease Testing Technologies and Emerging Markets
 
COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market
COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market
COVID-19 Impacts on the Global mRNA Vaccines and Therapeutics Market
 
Introduction to the pharmaceutical market and practice
Introduction to the pharmaceutical market and practiceIntroduction to the pharmaceutical market and practice
Introduction to the pharmaceutical market and practice
 
The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...
The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...
The U.S. Biopharmaceutical Industry (2014): Perspectives on Future Growth and...
 
Antibody drug conjugate market opportunity analysis
Antibody drug conjugate market opportunity analysisAntibody drug conjugate market opportunity analysis
Antibody drug conjugate market opportunity analysis
 
Pharma figures 2017 ; Efpia
Pharma figures 2017 ; EfpiaPharma figures 2017 ; Efpia
Pharma figures 2017 ; Efpia
 
Blog april2016 companycreation
Blog april2016 companycreationBlog april2016 companycreation
Blog april2016 companycreation
 

Similaire à Hungarian Investment and Trade Development Authority

Imre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystem
Imre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystemImre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystem
Imre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystemCUBCCE Conference
 
Μάκης Παπαταξιάρχης - 6th Clinical Research Conference
Μάκης Παπαταξιάρχης - 6th Clinical Research ConferenceΜάκης Παπαταξιάρχης - 6th Clinical Research Conference
Μάκης Παπαταξιάρχης - 6th Clinical Research ConferenceStarttech Ventures
 
Invest in Denmark Lifescience Cluster- Intro
Invest in Denmark Lifescience Cluster- IntroInvest in Denmark Lifescience Cluster- Intro
Invest in Denmark Lifescience Cluster- IntroPramila Das
 
Procurement: The Cornerstone of Market Access in Europe
Procurement: The Cornerstone of Market Access in EuropeProcurement: The Cornerstone of Market Access in Europe
Procurement: The Cornerstone of Market Access in EuropeMedTech Europe
 
Pharma in Switzerland
Pharma in SwitzerlandPharma in Switzerland
Pharma in SwitzerlandRichard Gorst
 
Finnish biotech year, Tero Piispanen
Finnish biotech year, Tero Piispanen Finnish biotech year, Tero Piispanen
Finnish biotech year, Tero Piispanen Business Turku
 
2013 09 25_ildiko_innovation at teva
2013 09 25_ildiko_innovation at teva2013 09 25_ildiko_innovation at teva
2013 09 25_ildiko_innovation at tevainnovationday2013
 
EuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle BenzimraEuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle BenzimraEuroBioForum
 
Health Valley Event Presentatie Rob ten Hoedt
Health Valley Event Presentatie Rob ten HoedtHealth Valley Event Presentatie Rob ten Hoedt
Health Valley Event Presentatie Rob ten HoedtHealth Valley
 
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...Business Turku
 
EuroBioForum 2013 - Day 2 | Frank Molina
EuroBioForum 2013 - Day 2 | Frank Molina EuroBioForum 2013 - Day 2 | Frank Molina
EuroBioForum 2013 - Day 2 | Frank MolinaEuroBioForum
 
IMI Graham Hughes
IMI Graham HughesIMI Graham Hughes
IMI Graham HughesCK Group
 
Uott uw brochure 04 2018
Uott uw brochure 04 2018Uott uw brochure 04 2018
Uott uw brochure 04 2018UOTT UW
 
Europe In-Vitro Diagnostics (IVD) Market
Europe In-Vitro Diagnostics (IVD) MarketEurope In-Vitro Diagnostics (IVD) Market
Europe In-Vitro Diagnostics (IVD) MarketRenub Research
 
H.A.E.Konarowski, Chemrar High-Teck Center
H.A.E.Konarowski, Chemrar High-Teck CenterH.A.E.Konarowski, Chemrar High-Teck Center
H.A.E.Konarowski, Chemrar High-Teck CenterPharmcluster
 
EPAD 2017 - Jan Willem Van de Loo
EPAD 2017 - Jan Willem Van de LooEPAD 2017 - Jan Willem Van de Loo
EPAD 2017 - Jan Willem Van de LooMarc van Gurp
 
Transfer of novel academic research in vaccines into marketable products – a ...
Transfer of novel academic research in vaccines into marketable products – a ...Transfer of novel academic research in vaccines into marketable products – a ...
Transfer of novel academic research in vaccines into marketable products – a ...BioAsia: The Global Bio Business Forum
 
4 nov 2010: Presentation Roland Lageveen on biotechnology in the NL.
4 nov 2010: Presentation Roland Lageveen on biotechnology in the NL. 4 nov 2010: Presentation Roland Lageveen on biotechnology in the NL.
4 nov 2010: Presentation Roland Lageveen on biotechnology in the NL. Life Sciences Health
 

Similaire à Hungarian Investment and Trade Development Authority (20)

ABA Life Sciences
ABA Life Sciences ABA Life Sciences
ABA Life Sciences
 
Imre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystem
Imre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystemImre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystem
Imre Kacskovics - The way toward a vibrant RDI red biotechnology ecosystem
 
Μάκης Παπαταξιάρχης - 6th Clinical Research Conference
Μάκης Παπαταξιάρχης - 6th Clinical Research ConferenceΜάκης Παπαταξιάρχης - 6th Clinical Research Conference
Μάκης Παπαταξιάρχης - 6th Clinical Research Conference
 
Invest in Denmark Lifescience Cluster- Intro
Invest in Denmark Lifescience Cluster- IntroInvest in Denmark Lifescience Cluster- Intro
Invest in Denmark Lifescience Cluster- Intro
 
Procurement: The Cornerstone of Market Access in Europe
Procurement: The Cornerstone of Market Access in EuropeProcurement: The Cornerstone of Market Access in Europe
Procurement: The Cornerstone of Market Access in Europe
 
Pharma in Switzerland
Pharma in SwitzerlandPharma in Switzerland
Pharma in Switzerland
 
Finnish biotech year, Tero Piispanen
Finnish biotech year, Tero Piispanen Finnish biotech year, Tero Piispanen
Finnish biotech year, Tero Piispanen
 
2013 09 25_ildiko_innovation at teva
2013 09 25_ildiko_innovation at teva2013 09 25_ildiko_innovation at teva
2013 09 25_ildiko_innovation at teva
 
efpIA Figures key data_2013
efpIA Figures key data_2013efpIA Figures key data_2013
efpIA Figures key data_2013
 
EuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle BenzimraEuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
EuroBioForum 2013 - Day 1 | Emmanuelle Benzimra
 
Health Valley Event Presentatie Rob ten Hoedt
Health Valley Event Presentatie Rob ten HoedtHealth Valley Event Presentatie Rob ten Hoedt
Health Valley Event Presentatie Rob ten Hoedt
 
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...
HealthBIO 2021_Orion’s new strategy and industry trends seen from a midsize p...
 
EuroBioForum 2013 - Day 2 | Frank Molina
EuroBioForum 2013 - Day 2 | Frank Molina EuroBioForum 2013 - Day 2 | Frank Molina
EuroBioForum 2013 - Day 2 | Frank Molina
 
IMI Graham Hughes
IMI Graham HughesIMI Graham Hughes
IMI Graham Hughes
 
Uott uw brochure 04 2018
Uott uw brochure 04 2018Uott uw brochure 04 2018
Uott uw brochure 04 2018
 
Europe In-Vitro Diagnostics (IVD) Market
Europe In-Vitro Diagnostics (IVD) MarketEurope In-Vitro Diagnostics (IVD) Market
Europe In-Vitro Diagnostics (IVD) Market
 
H.A.E.Konarowski, Chemrar High-Teck Center
H.A.E.Konarowski, Chemrar High-Teck CenterH.A.E.Konarowski, Chemrar High-Teck Center
H.A.E.Konarowski, Chemrar High-Teck Center
 
EPAD 2017 - Jan Willem Van de Loo
EPAD 2017 - Jan Willem Van de LooEPAD 2017 - Jan Willem Van de Loo
EPAD 2017 - Jan Willem Van de Loo
 
Transfer of novel academic research in vaccines into marketable products – a ...
Transfer of novel academic research in vaccines into marketable products – a ...Transfer of novel academic research in vaccines into marketable products – a ...
Transfer of novel academic research in vaccines into marketable products – a ...
 
4 nov 2010: Presentation Roland Lageveen on biotechnology in the NL.
4 nov 2010: Presentation Roland Lageveen on biotechnology in the NL. 4 nov 2010: Presentation Roland Lageveen on biotechnology in the NL.
4 nov 2010: Presentation Roland Lageveen on biotechnology in the NL.
 

Dernier

FEXLE- Salesforce Field Service Lightning
FEXLE- Salesforce Field Service LightningFEXLE- Salesforce Field Service Lightning
FEXLE- Salesforce Field Service LightningFEXLE
 
Salesforce in Life Sciences - Best Ways to Leverage The CRM for Clinical Trials
Salesforce in Life Sciences - Best Ways to Leverage The CRM for Clinical TrialsSalesforce in Life Sciences - Best Ways to Leverage The CRM for Clinical Trials
Salesforce in Life Sciences - Best Ways to Leverage The CRM for Clinical TrialsFEXLE
 
Falcon Invoice Discounting Setup for Small Businesses
Falcon Invoice Discounting Setup for Small BusinessesFalcon Invoice Discounting Setup for Small Businesses
Falcon Invoice Discounting Setup for Small BusinessesFalcon investment
 
Hyundai capital 2024 1q Earnings release
Hyundai capital 2024 1q Earnings releaseHyundai capital 2024 1q Earnings release
Hyundai capital 2024 1q Earnings releaseirhcs
 
Unlock Your TikTok Potential: Free TikTok Likes with InstBlast
Unlock Your TikTok Potential: Free TikTok Likes with InstBlastUnlock Your TikTok Potential: Free TikTok Likes with InstBlast
Unlock Your TikTok Potential: Free TikTok Likes with InstBlastInstBlast Marketing
 
Event Report - IBM Think 2024 - It is all about AI and hybrid
Event Report - IBM Think 2024 - It is all about AI and hybridEvent Report - IBM Think 2024 - It is all about AI and hybrid
Event Report - IBM Think 2024 - It is all about AI and hybridHolger Mueller
 
Equinox Gold Corporate Deck May 24th 2024
Equinox Gold Corporate Deck May 24th 2024Equinox Gold Corporate Deck May 24th 2024
Equinox Gold Corporate Deck May 24th 2024Equinox Gold Corp.
 
What is social media.pdf Social media refers to digital platforms and applica...
What is social media.pdf Social media refers to digital platforms and applica...What is social media.pdf Social media refers to digital platforms and applica...
What is social media.pdf Social media refers to digital platforms and applica...AnaBeatriz125525
 
TriStar Gold Corporate Presentation May 2024
TriStar Gold Corporate Presentation May 2024TriStar Gold Corporate Presentation May 2024
TriStar Gold Corporate Presentation May 2024Adnet Communications
 
Evolution and Growth of Supply chain.pdf
Evolution and Growth of Supply chain.pdfEvolution and Growth of Supply chain.pdf
Evolution and Growth of Supply chain.pdfGutaMengesha1
 
zidauu _business communication.pptx /pdf
zidauu _business communication.pptx /pdfzidauu _business communication.pptx /pdf
zidauu _business communication.pptx /pdfzukhrafshabbir
 
Constitution of Company Article of Association
Constitution of Company Article of AssociationConstitution of Company Article of Association
Constitution of Company Article of Associationseri bangash
 
India’s Recommended Women Surgeons to Watch in 2024.pdf
India’s Recommended Women Surgeons to Watch in 2024.pdfIndia’s Recommended Women Surgeons to Watch in 2024.pdf
India’s Recommended Women Surgeons to Watch in 2024.pdfCIOLOOKIndia
 
Unveiling the Dynamic Gemini_ Personality Traits and Sign Dates.pptx
Unveiling the Dynamic Gemini_ Personality Traits and Sign Dates.pptxUnveiling the Dynamic Gemini_ Personality Traits and Sign Dates.pptx
Unveiling the Dynamic Gemini_ Personality Traits and Sign Dates.pptxmy Pandit
 
How to Maintain Healthy Life style.pptx
How to Maintain Healthy Life style.pptxHow to Maintain Healthy Life style.pptx
How to Maintain Healthy Life style.pptxrdishurana
 
IPTV Subscription UK: Your Guide to Choosing the Best Service
IPTV Subscription UK: Your Guide to Choosing the Best ServiceIPTV Subscription UK: Your Guide to Choosing the Best Service
IPTV Subscription UK: Your Guide to Choosing the Best ServiceDragon Dream Bar
 
Pitch Deck Teardown: Terra One's $7.5m Seed deck
Pitch Deck Teardown: Terra One's $7.5m Seed deckPitch Deck Teardown: Terra One's $7.5m Seed deck
Pitch Deck Teardown: Terra One's $7.5m Seed deckHajeJanKamps
 
The Truth About Dinesh Bafna's Situation.pdf
The Truth About Dinesh Bafna's Situation.pdfThe Truth About Dinesh Bafna's Situation.pdf
The Truth About Dinesh Bafna's Situation.pdfMont Surfaces
 
Using Generative AI for Content Marketing
Using Generative AI for Content MarketingUsing Generative AI for Content Marketing
Using Generative AI for Content MarketingChuck Aikens
 
Series A Fundraising Guide (Investing Individuals Improving Our World) by Accion
Series A Fundraising Guide (Investing Individuals Improving Our World) by AccionSeries A Fundraising Guide (Investing Individuals Improving Our World) by Accion
Series A Fundraising Guide (Investing Individuals Improving Our World) by AccionAlejandro Cremades
 

Dernier (20)

FEXLE- Salesforce Field Service Lightning
FEXLE- Salesforce Field Service LightningFEXLE- Salesforce Field Service Lightning
FEXLE- Salesforce Field Service Lightning
 
Salesforce in Life Sciences - Best Ways to Leverage The CRM for Clinical Trials
Salesforce in Life Sciences - Best Ways to Leverage The CRM for Clinical TrialsSalesforce in Life Sciences - Best Ways to Leverage The CRM for Clinical Trials
Salesforce in Life Sciences - Best Ways to Leverage The CRM for Clinical Trials
 
Falcon Invoice Discounting Setup for Small Businesses
Falcon Invoice Discounting Setup for Small BusinessesFalcon Invoice Discounting Setup for Small Businesses
Falcon Invoice Discounting Setup for Small Businesses
 
Hyundai capital 2024 1q Earnings release
Hyundai capital 2024 1q Earnings releaseHyundai capital 2024 1q Earnings release
Hyundai capital 2024 1q Earnings release
 
Unlock Your TikTok Potential: Free TikTok Likes with InstBlast
Unlock Your TikTok Potential: Free TikTok Likes with InstBlastUnlock Your TikTok Potential: Free TikTok Likes with InstBlast
Unlock Your TikTok Potential: Free TikTok Likes with InstBlast
 
Event Report - IBM Think 2024 - It is all about AI and hybrid
Event Report - IBM Think 2024 - It is all about AI and hybridEvent Report - IBM Think 2024 - It is all about AI and hybrid
Event Report - IBM Think 2024 - It is all about AI and hybrid
 
Equinox Gold Corporate Deck May 24th 2024
Equinox Gold Corporate Deck May 24th 2024Equinox Gold Corporate Deck May 24th 2024
Equinox Gold Corporate Deck May 24th 2024
 
What is social media.pdf Social media refers to digital platforms and applica...
What is social media.pdf Social media refers to digital platforms and applica...What is social media.pdf Social media refers to digital platforms and applica...
What is social media.pdf Social media refers to digital platforms and applica...
 
TriStar Gold Corporate Presentation May 2024
TriStar Gold Corporate Presentation May 2024TriStar Gold Corporate Presentation May 2024
TriStar Gold Corporate Presentation May 2024
 
Evolution and Growth of Supply chain.pdf
Evolution and Growth of Supply chain.pdfEvolution and Growth of Supply chain.pdf
Evolution and Growth of Supply chain.pdf
 
zidauu _business communication.pptx /pdf
zidauu _business communication.pptx /pdfzidauu _business communication.pptx /pdf
zidauu _business communication.pptx /pdf
 
Constitution of Company Article of Association
Constitution of Company Article of AssociationConstitution of Company Article of Association
Constitution of Company Article of Association
 
India’s Recommended Women Surgeons to Watch in 2024.pdf
India’s Recommended Women Surgeons to Watch in 2024.pdfIndia’s Recommended Women Surgeons to Watch in 2024.pdf
India’s Recommended Women Surgeons to Watch in 2024.pdf
 
Unveiling the Dynamic Gemini_ Personality Traits and Sign Dates.pptx
Unveiling the Dynamic Gemini_ Personality Traits and Sign Dates.pptxUnveiling the Dynamic Gemini_ Personality Traits and Sign Dates.pptx
Unveiling the Dynamic Gemini_ Personality Traits and Sign Dates.pptx
 
How to Maintain Healthy Life style.pptx
How to Maintain Healthy Life style.pptxHow to Maintain Healthy Life style.pptx
How to Maintain Healthy Life style.pptx
 
IPTV Subscription UK: Your Guide to Choosing the Best Service
IPTV Subscription UK: Your Guide to Choosing the Best ServiceIPTV Subscription UK: Your Guide to Choosing the Best Service
IPTV Subscription UK: Your Guide to Choosing the Best Service
 
Pitch Deck Teardown: Terra One's $7.5m Seed deck
Pitch Deck Teardown: Terra One's $7.5m Seed deckPitch Deck Teardown: Terra One's $7.5m Seed deck
Pitch Deck Teardown: Terra One's $7.5m Seed deck
 
The Truth About Dinesh Bafna's Situation.pdf
The Truth About Dinesh Bafna's Situation.pdfThe Truth About Dinesh Bafna's Situation.pdf
The Truth About Dinesh Bafna's Situation.pdf
 
Using Generative AI for Content Marketing
Using Generative AI for Content MarketingUsing Generative AI for Content Marketing
Using Generative AI for Content Marketing
 
Series A Fundraising Guide (Investing Individuals Improving Our World) by Accion
Series A Fundraising Guide (Investing Individuals Improving Our World) by AccionSeries A Fundraising Guide (Investing Individuals Improving Our World) by Accion
Series A Fundraising Guide (Investing Individuals Improving Our World) by Accion
 

Hungarian Investment and Trade Development Authority

  • 1.  
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13. Competitive wages compared to Western Europe Source: Mercer, 2007
  • 14.